Repligen
RGEN
#2039
Rank
A$14.10 B
Marketcap
A$250.53
Share price
-0.46%
Change (1 day)
8.10%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of September 2025 : A$4.41 Billion

According to Repligen 's latest financial reports the company's total assets are A$4.41 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$4.54 B9.48%
2023-12-31A$4.15 B11.7%
2022-12-31A$3.72 B14.36%
2021-12-31A$3.25 B31.45%
2020-12-31A$2.47 B23.75%
2019-12-31A$1.99 B81.87%
2018-12-31A$1.09 B15.46%
2017-12-31A$0.95 B137.61%
2016-12-31A$0.40 B99.67%
2015-12-31A$0.20 B28.05%
2014-12-31A$0.15 B17.85%
2013-12-31A$0.13 B42.49%
2012-12-31A$93.35 M
2011-03-31A$69.95 M-9.82%
2010-03-31A$77.57 M-26.48%
2009-03-31A$0.10 B41.17%
2008-03-31A$74.74 M107.69%
2007-03-31A$35.98 M-11.18%
2006-03-31A$40.51 M13.42%
2005-03-31A$35.72 M-9.11%
2004-03-31A$39.3 M-11.5%
2003-03-31A$44.41 M-18.6%
2002-03-31A$54.56 M-17.97%
2001-03-31A$66.51 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novavax
NVAX
A$1.78 B-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$11.50 B 160.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$6.44 B 45.90%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$193.82 B 4,286.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$155.70 B 3,423.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$146.43 B 3,213.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$315.47 B 7,039.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$3.81 B-13.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$0.13 B-96.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$11.35 B 157.00%๐Ÿ‡บ๐Ÿ‡ธ USA